ASTEC · Basic Materials · Agricultural Inputs
Composite scorecard: 5/100 — Quality 8 · Momentum 0
| Share price | ₹685.85 |
| Market cap | ₹1,536 Cr |
| P/B ratio | 3.9 |
| ROE | -97.5% |
| ROCE | -10.6% |
| Book value | ₹175.23 |
| Year | Sales | Net profit | OPM |
|---|---|---|---|
| 2026 | ₹448 Cr | ₹-81 Cr | -1.0% |
| 2025 | ₹381 Cr | ₹-135 Cr | -17.0% |
| 2024 | ₹458 Cr | ₹-47 Cr | -1.0% |
| 2023 | ₹628 Cr | ₹26 Cr | 12.0% |
| 2022 | ₹677 Cr | ₹90 Cr | 23.0% |
Astec LifeSciences Limited, together with its subsidiaries, manufactures and sells agrochemical active ingredients and pharmaceutical intermediates in India. The company provides triazole fungicides for use in field crops; foliar treatment for the control of scab, powdery mildew, shot-hole, blossom blight, and rust; seed treatment for the control of seed and soil-borne diseases in cotton and maize, as well as grains, such as barley, rice, and wheat; post-harvest drench; and food additive and wood preservatives. It also provides herbicides, insecticides, and specialty chemical products. The com